International Association for Cannabis as Medicine February 2020 Bulletin

The International Association for Cannabis as Medicine’s February 2nd Bulletin (linked here) features links to studies and new data on the latest environmental, economic, scientific and international issues of cannabis, including the effectiveness of Cannabigerol against infections with antibiotic-resistant bacteria, on how much electricity the cannabis industry consumes, on the the status of WHO cannabis scheduling in the EU, and on cannabis use for arthritis and insomnia associated with chronic pain.

The Bulletin’s news brief coverage includes links to studies and new data on the anti-psychotic effect of CBD, on the effectiveness of Beta-caryophyllene and arginine in treating diabetes, and on how THC improves optic nerve head blood flow, which may be beneficial in the treatment of glaucoma.